img

Global Valacyclovir Oral Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valacyclovir Oral Market Insights, Forecast to 2034

Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
Global Valacyclovir Oral market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Valacyclovir Oral industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Valacyclovir Oral key manufacturers include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals and Time Cap Labs, etc. GSK, Sandoz, Sun Pharmaceutical are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Valacyclovir Oral were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Valacyclovir Oral market and estimated to attract more attentions from industry insiders and investors.
Valacyclovir Oral can be divided into 500mg Tablet, 1000mg Tablet, 300mg Tablet and Others, etc. 500mg Tablet is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Valacyclovir Oral is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Valacyclovir Oral industry development. In 2022, global % sales of Valacyclovir Oral went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Valacyclovir Oral market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Valacyclovir Oral market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Segment by Type
500mg Tablet
1000mg Tablet
300mg Tablet
Others

Segment by Application


Hospital
Drug Store

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Valacyclovir Oral plant distribution, commercial date of Valacyclovir Oral, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Valacyclovir Oral introduction, etc. Valacyclovir Oral Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Valacyclovir Oral
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Valacyclovir Oral Product Introduction
1.2 Market by Type
1.2.1 Global Valacyclovir Oral Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 500mg Tablet
1.2.3 1000mg Tablet
1.2.4 300mg Tablet
1.2.5 Others
1.3 Market by Application
1.3.1 Global Valacyclovir Oral Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valacyclovir Oral Sales Estimates and Forecasts 2018-2029
2.2 Global Valacyclovir Oral Revenue by Region
2.2.1 Global Valacyclovir Oral Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Valacyclovir Oral Revenue by Region (2018-2024)
2.2.3 Global Valacyclovir Oral Revenue by Region (2024-2029)
2.2.4 Global Valacyclovir Oral Revenue Market Share by Region (2018-2029)
2.3 Global Valacyclovir Oral Sales Estimates and Forecasts 2018-2029
2.4 Global Valacyclovir Oral Sales by Region
2.4.1 Global Valacyclovir Oral Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Valacyclovir Oral Sales by Region (2018-2024)
2.4.3 Global Valacyclovir Oral Sales by Region (2024-2029)
2.4.4 Global Valacyclovir Oral Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Valacyclovir Oral Sales by Manufacturers
3.1.1 Global Valacyclovir Oral Sales by Manufacturers (2018-2024)
3.1.2 Global Valacyclovir Oral Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valacyclovir Oral in 2022
3.2 Global Valacyclovir Oral Revenue by Manufacturers
3.2.1 Global Valacyclovir Oral Revenue by Manufacturers (2018-2024)
3.2.2 Global Valacyclovir Oral Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Valacyclovir Oral Revenue in 2022
3.3 Global Key Players of Valacyclovir Oral, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Valacyclovir Oral Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valacyclovir Oral, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valacyclovir Oral, Product Offered and Application
3.8 Global Key Manufacturers of Valacyclovir Oral, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valacyclovir Oral Sales by Type
4.1.1 Global Valacyclovir Oral Historical Sales by Type (2018-2024)
4.1.2 Global Valacyclovir Oral Forecasted Sales by Type (2024-2029)
4.1.3 Global Valacyclovir Oral Sales Market Share by Type (2018-2029)
4.2 Global Valacyclovir Oral Revenue by Type
4.2.1 Global Valacyclovir Oral Historical Revenue by Type (2018-2024)
4.2.2 Global Valacyclovir Oral Forecasted Revenue by Type (2024-2029)
4.2.3 Global Valacyclovir Oral Revenue Market Share by Type (2018-2029)
4.3 Global Valacyclovir Oral Price by Type
4.3.1 Global Valacyclovir Oral Price by Type (2018-2024)
4.3.2 Global Valacyclovir Oral Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Valacyclovir Oral Sales by Application
5.1.1 Global Valacyclovir Oral Historical Sales by Application (2018-2024)
5.1.2 Global Valacyclovir Oral Forecasted Sales by Application (2024-2029)
5.1.3 Global Valacyclovir Oral Sales Market Share by Application (2018-2029)
5.2 Global Valacyclovir Oral Revenue by Application
5.2.1 Global Valacyclovir Oral Historical Revenue by Application (2018-2024)
5.2.2 Global Valacyclovir Oral Forecasted Revenue by Application (2024-2029)
5.2.3 Global Valacyclovir Oral Revenue Market Share by Application (2018-2029)
5.3 Global Valacyclovir Oral Price by Application
5.3.1 Global Valacyclovir Oral Price by Application (2018-2024)
5.3.2 Global Valacyclovir Oral Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Valacyclovir Oral Market Size by Type
6.1.1 US & Canada Valacyclovir Oral Sales by Type (2018-2029)
6.1.2 US & Canada Valacyclovir Oral Revenue by Type (2018-2029)
6.2 US & Canada Valacyclovir Oral Market Size by Application
6.2.1 US & Canada Valacyclovir Oral Sales by Application (2018-2029)
6.2.2 US & Canada Valacyclovir Oral Revenue by Application (2018-2029)
6.3 US & Canada Valacyclovir Oral Market Size by Country
6.3.1 US & Canada Valacyclovir Oral Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Valacyclovir Oral Sales by Country (2018-2029)
6.3.3 US & Canada Valacyclovir Oral Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Valacyclovir Oral Market Size by Type
7.1.1 Europe Valacyclovir Oral Sales by Type (2018-2029)
7.1.2 Europe Valacyclovir Oral Revenue by Type (2018-2029)
7.2 Europe Valacyclovir Oral Market Size by Application
7.2.1 Europe Valacyclovir Oral Sales by Application (2018-2029)
7.2.2 Europe Valacyclovir Oral Revenue by Application (2018-2029)
7.3 Europe Valacyclovir Oral Market Size by Country
7.3.1 Europe Valacyclovir Oral Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Valacyclovir Oral Sales by Country (2018-2029)
7.3.3 Europe Valacyclovir Oral Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Valacyclovir Oral Market Size
8.1.1 China Valacyclovir Oral Sales (2018-2029)
8.1.2 China Valacyclovir Oral Revenue (2018-2029)
8.2 China Valacyclovir Oral Market Size by Application
8.2.1 China Valacyclovir Oral Sales by Application (2018-2029)
8.2.2 China Valacyclovir Oral Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Valacyclovir Oral Market Size by Type
9.1.1 Asia Valacyclovir Oral Sales by Type (2018-2029)
9.1.2 Asia Valacyclovir Oral Revenue by Type (2018-2029)
9.2 Asia Valacyclovir Oral Market Size by Application
9.2.1 Asia Valacyclovir Oral Sales by Application (2018-2029)
9.2.2 Asia Valacyclovir Oral Revenue by Application (2018-2029)
9.3 Asia Valacyclovir Oral Sales by Region
9.3.1 Asia Valacyclovir Oral Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Valacyclovir Oral Revenue by Region (2018-2029)
9.3.3 Asia Valacyclovir Oral Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valacyclovir Oral Market Size by Type
10.1.1 Middle East, Africa and Latin America Valacyclovir Oral Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Valacyclovir Oral Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Valacyclovir Oral Market Size by Application
10.2.1 Middle East, Africa and Latin America Valacyclovir Oral Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Valacyclovir Oral Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Valacyclovir Oral Sales by Country
10.3.1 Middle East, Africa and Latin America Valacyclovir Oral Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Valacyclovir Oral Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Valacyclovir Oral Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Sandoz
11.2.1 Sandoz Company Information
11.2.2 Sandoz Overview
11.2.3 Sandoz Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sandoz Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sandoz Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Information
11.3.2 Sun Pharmaceutical Overview
11.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sun Pharmaceutical Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Recent Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Overview
11.4.3 Cipla Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cipla Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Overview
11.5.3 Mylan Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Overview
11.6.3 Teva Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Teva Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Zydus Pharmaceuticals
11.7.1 Zydus Pharmaceuticals Company Information
11.7.2 Zydus Pharmaceuticals Overview
11.7.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Zydus Pharmaceuticals Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zydus Pharmaceuticals Recent Developments
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Information
11.8.2 West-Ward Pharmaceuticals Overview
11.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 West-Ward Pharmaceuticals Recent Developments
11.9 Time Cap Labs
11.9.1 Time Cap Labs Company Information
11.9.2 Time Cap Labs Overview
11.9.3 Time Cap Labs Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Time Cap Labs Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Time Cap Labs Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Company Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Wockhardt Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wockhardt Recent Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Overview
11.11.3 Apotex Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Apotex Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Apotex Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Aurobindo Pharma Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Jubilant Pharma
11.13.1 Jubilant Pharma Company Information
11.13.2 Jubilant Pharma Overview
11.13.3 Jubilant Pharma Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Jubilant Pharma Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jubilant Pharma Recent Developments
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Information
11.14.2 Lunan Pharmaceutical Overview
11.14.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Lunan Pharmaceutical Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lunan Pharmaceutical Recent Developments
11.15 Shandong Luoxin Pharmaceutical Group
11.15.1 Shandong Luoxin Pharmaceutical Group Company Information
11.15.2 Shandong Luoxin Pharmaceutical Group Overview
11.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shandong Luoxin Pharmaceutical Group Recent Developments
11.16 Tasly
11.16.1 Tasly Company Information
11.16.2 Tasly Overview
11.16.3 Tasly Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Tasly Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Tasly Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valacyclovir Oral Industry Chain Analysis
12.2 Valacyclovir Oral Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valacyclovir Oral Production Mode & Process
12.4 Valacyclovir Oral Sales and Marketing
12.4.1 Valacyclovir Oral Sales Channels
12.4.2 Valacyclovir Oral Distributors
12.5 Valacyclovir Oral Customers
13 Market Dynamics
13.1 Valacyclovir Oral Industry Trends
13.2 Valacyclovir Oral Market Drivers
13.3 Valacyclovir Oral Market Challenges
13.4 Valacyclovir Oral Market Restraints
14 Key Findings in The Global Valacyclovir Oral Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Valacyclovir Oral Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 500mg Tablet
Table 3. Major Manufacturers of 1000mg Tablet
Table 4. Major Manufacturers of 300mg Tablet
Table 5. Major Manufacturers of Others
Table 6. Global Valacyclovir Oral Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Valacyclovir Oral Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Valacyclovir Oral Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Valacyclovir Oral Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Valacyclovir Oral Revenue Market Share by Region (2018-2024)
Table 11. Global Valacyclovir Oral Revenue Market Share by Region (2024-2029)
Table 12. Global Valacyclovir Oral Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Valacyclovir Oral Sales by Region (2018-2024) & (K Units)
Table 14. Global Valacyclovir Oral Sales by Region (2024-2029) & (K Units)
Table 15. Global Valacyclovir Oral Sales Market Share by Region (2018-2024)
Table 16. Global Valacyclovir Oral Sales Market Share by Region (2024-2029)
Table 17. Global Valacyclovir Oral Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Valacyclovir Oral Sales Share by Manufacturers (2018-2024)
Table 19. Global Valacyclovir Oral Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Valacyclovir Oral Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Valacyclovir Oral, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Valacyclovir Oral Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Valacyclovir Oral Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Valacyclovir Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir Oral as of 2022)
Table 25. Global Key Manufacturers of Valacyclovir Oral, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Valacyclovir Oral, Product Offered and Application
Table 27. Global Key Manufacturers of Valacyclovir Oral, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 30. Global Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 31. Global Valacyclovir Oral Sales Share by Type (2018-2024)
Table 32. Global Valacyclovir Oral Sales Share by Type (2024-2029)
Table 33. Global Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Valacyclovir Oral Revenue Share by Type (2018-2024)
Table 36. Global Valacyclovir Oral Revenue Share by Type (2024-2029)
Table 37. Valacyclovir Oral Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Valacyclovir Oral Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 40. Global Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 41. Global Valacyclovir Oral Sales Share by Application (2018-2024)
Table 42. Global Valacyclovir Oral Sales Share by Application (2024-2029)
Table 43. Global Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Valacyclovir Oral Revenue Share by Application (2018-2024)
Table 46. Global Valacyclovir Oral Revenue Share by Application (2024-2029)
Table 47. Valacyclovir Oral Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Valacyclovir Oral Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Valacyclovir Oral Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Valacyclovir Oral Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Valacyclovir Oral Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 62. Europe Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 63. Europe Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 64. Europe Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 67. Europe Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 68. Europe Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Valacyclovir Oral Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Valacyclovir Oral Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Valacyclovir Oral Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 74. Europe Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 75. China Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 76. China Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 77. China Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 80. China Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 81. China Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 84. Asia Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 85. Asia Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 88. Asia Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 89. Asia Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Valacyclovir Oral Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Valacyclovir Oral Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Valacyclovir Oral Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Valacyclovir Oral Sales by Region (2018-2024) & (K Units)
Table 95. Asia Valacyclovir Oral Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Valacyclovir Oral Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Valacyclovir Oral Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 109. GSK Company Information
Table 110. GSK Description and Major Businesses
Table 111. GSK Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. GSK Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. GSK Recent Developments
Table 114. Sandoz Company Information
Table 115. Sandoz Description and Major Businesses
Table 116. Sandoz Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sandoz Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sandoz Recent Developments
Table 119. Sun Pharmaceutical Company Information
Table 120. Sun Pharmaceutical Description and Major Businesses
Table 121. Sun Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Sun Pharmaceutical Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Sun Pharmaceutical Recent Developments
Table 124. Cipla Company Information
Table 125. Cipla Description and Major Businesses
Table 126. Cipla Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Cipla Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Cipla Recent Developments
Table 129. Mylan Company Information
Table 130. Mylan Description and Major Businesses
Table 131. Mylan Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Mylan Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Mylan Recent Developments
Table 134. Teva Company Information
Table 135. Teva Description and Major Businesses
Table 136. Teva Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Teva Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Teva Recent Developments
Table 139. Zydus Pharmaceuticals Company Information
Table 140. Zydus Pharmaceuticals Description and Major Businesses
Table 141. Zydus Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Zydus Pharmaceuticals Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Zydus Pharmaceuticals Recent Developments
Table 144. West-Ward Pharmaceuticals Company Information
Table 145. West-Ward Pharmaceuticals Description and Major Businesses
Table 146. West-Ward Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. West-Ward Pharmaceuticals Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. West-Ward Pharmaceuticals Recent Developments
Table 149. Time Cap Labs Company Information
Table 150. Time Cap Labs Description and Major Businesses
Table 151. Time Cap Labs Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Time Cap Labs Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Time Cap Labs Recent Developments
Table 154. Wockhardt Company Information
Table 155. Wockhardt Description and Major Businesses
Table 156. Wockhardt Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Wockhardt Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Wockhardt Recent Developments
Table 159. Apotex Company Information
Table 160. Apotex Description and Major Businesses
Table 161. Apotex Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Apotex Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Apotex Recent Developments
Table 164. Aurobindo Pharma Company Information
Table 165. Aurobindo Pharma Description and Major Businesses
Table 166. Aurobindo Pharma Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Aurobindo Pharma Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Aurobindo Pharma Recent Developments
Table 169. Jubilant Pharma Company Information
Table 170. Jubilant Pharma Description and Major Businesses
Table 171. Jubilant Pharma Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Jubilant Pharma Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Jubilant Pharma Recent Developments
Table 174. Lunan Pharmaceutical Company Information
Table 175. Lunan Pharmaceutical Description and Major Businesses
Table 176. Lunan Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Lunan Pharmaceutical Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Lunan Pharmaceutical Recent Developments
Table 179. Shandong Luoxin Pharmaceutical Group Company Information
Table 180. Shandong Luoxin Pharmaceutical Group Description and Major Businesses
Table 181. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Shandong Luoxin Pharmaceutical Group Recent Developments
Table 184. Tasly Company Information
Table 185. Tasly Description and Major Businesses
Table 186. Tasly Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Tasly Valacyclovir Oral Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Tasly Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Valacyclovir Oral Distributors List
Table 192. Valacyclovir Oral Customers List
Table 193. Valacyclovir Oral Market Trends
Table 194. Valacyclovir Oral Market Drivers
Table 195. Valacyclovir Oral Market Challenges
Table 196. Valacyclovir Oral Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Valacyclovir Oral Product Picture
Figure 2. Global Valacyclovir Oral Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Valacyclovir Oral Market Share by Type in 2022 & 2029
Figure 4. 500mg Tablet Product Picture
Figure 5. 1000mg Tablet Product Picture
Figure 6. 300mg Tablet Product Picture
Figure 7. Others Product Picture
Figure 8. Global Valacyclovir Oral Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Valacyclovir Oral Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Valacyclovir Oral Report Years Considered
Figure 13. Global Valacyclovir Oral Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Valacyclovir Oral Revenue 2018-2029 (US$ Million)
Figure 15. Global Valacyclovir Oral Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Valacyclovir Oral Revenue Market Share by Region (2018-2029)
Figure 17. Global Valacyclovir Oral Sales 2018-2029 ((K Units)
Figure 18. Global Valacyclovir Oral Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Valacyclovir Oral Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Valacyclovir Oral Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Valacyclovir Oral Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Valacyclovir Oral Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Valacyclovir Oral Sales YoY (2018-2029) & (K Units)
Figure 24. China Valacyclovir Oral Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Valacyclovir Oral Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Valacyclovir Oral Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Valacyclovir Oral Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Valacyclovir Oral Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Valacyclovir Oral Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Valacyclovir Oral in the World: Market Share by Valacyclovir Oral Revenue in 2022
Figure 31. Global Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 33. Global Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 34. Global Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 35. Global Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Valacyclovir Oral Revenue Share by Country (2018-2029)
Figure 41. US & Canada Valacyclovir Oral Sales Share by Country (2018-2029)
Figure 42. U.S. Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 45. Europe Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 46. Europe Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 47. Europe Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 48. Europe Valacyclovir Oral Revenue Share by Country (2018-2029)
Figure 49. Europe Valacyclovir Oral Sales Share by Country (2018-2029)
Figure 50. Germany Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 51. France Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 55. China Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 56. China Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 57. China Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 58. China Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 59. Asia Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 60. Asia Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 61. Asia Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 62. Asia Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 63. Asia Valacyclovir Oral Revenue Share by Region (2018-2029)
Figure 64. Asia Valacyclovir Oral Sales Share by Region (2018-2029)
Figure 65. Japan Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 69. India Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Valacyclovir Oral Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Valacyclovir Oral Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Valacyclovir Oral Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Valacyclovir Oral Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Valacyclovir Oral Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Valacyclovir Oral Sales Share by Country (2018-2029)
Figure 76. Brazil Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Valacyclovir Oral Revenue (2018-2029) & (US$ Million)
Figure 81. Valacyclovir Oral Value Chain
Figure 82. Valacyclovir Oral Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries